Table 2.

Correlation of NSDHL expression with clinicopathological features in gastric cancer

Clinicopathological features	NSDHL (‐)	NSDHL (+)	Case	p‐values*
Histology classification
Adenocarcinoma	20 (18.7%)	87 (81.3%)	107	.663
Signet‐ring cell carcinoma	5 (22.7%)	17 (77.3%)	22
pT
T1 + T2	17 (28.8%)	42 (71.2%)	59	.013
T3 + T4	8 (11.4%)	62 (88.6%)	70
pN
pN0	13 (23.2%)	43 (76.8%)	56	.402
pN1 + pN2	8 (20.5%)	31 (79.5%)	39
pN3a + pN3b	4 (11.8%)	30 (88.2%)	34
pM
pM0	25 (20.3%)	98 (79.7%)	123	‐
pM1	0	6 (‐)	6

^*The p‐values were determined by the chi‐square test.